Oxygenta Pharmaceutical Fair Value
Oxygenta Pharmaceutical fair value. Oxygenta Pharmaceutical (OXYGENTAPH) average fair value is ₹106.09 across 1 valuation models — Price-to-Sales Valuation, vs a current market price of ₹47.75 (+122.18%), fair value range ₹106.09–₹106.09. Explore Oxygenta Pharmaceutical intrinsic worth to estimate fundamental worth using multiple valuation models.
Fair Value Analysis Export
OXYGENTAPH Fair Value vs Current Price — Valuation Summary
OXYGENTAPH average fair value, fair value range, price gap and valuation status across 1 models: Price-to-Sales Valuation. Check Oxygenta Pharmaceutical market cap to track the company's total market size over time.
Price-to-Sales Valuation
OXYGENTAPH Fair Value Analysis — Data Sources & Coverage
Oxygenta Pharmaceutical financial data sources, valuation methods applied and sector benchmarks used. For live price and a broader fundamental view, visit OXYGENTAPH share price screener.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
OXYGENTAPH vs Healthcare Sector Peers — P/E, P/B & Market Cap
Oxygenta Pharmaceutical P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Emcure Pharmaceuticals | EMCURE | 35.85 | 7.38 | ₹37,156 |
| Divis Laboratories | DIVISLAB | 84.36 | 14.72 | ₹244,125 |
| Aurobindo Pharma | AUROPHARMA | 25.97 | 2.54 | ₹96,479 |
| Syngene International | SYNGENE | 65.37 | 2.98 | ₹14,538 |
| Sat Kartar Life | SATKARTAR | 16.56 | 4.14 | ₹307 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.